Medtecs International logo

546 - Medtecs International Share Price

S$1.22 -0.0  -0.8%

Last Trade - 25/09/20

Sector
Healthcare
Size
Mid Cap
Market Cap £382.3m
Enterprise Value £404.7m
Revenue £56.3m
Position in Universe th / 6001
Bullish
Bearish
Unlock 546 Revenue
Momentum
Relative Strength (%)
1m -17.8%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -38.4%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
1,773 1,706 1,988 1,719 1,900 2,099 +3.4%
-47.4 -36.5 +24.3 +57.2 -11.0 +3.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2018, Medtecs International Co Ltd (TDR) revenues increased 10% to NT$2.1B. Net income increased 4% to NT$28.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Operating Expenses increase of 6% to NT$235.4M (expense), Interest Expenses increase of 13% to NT$61.4M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

546 Revenue Unlock 546 Revenue

Net Income

546 Net Income Unlock 546 Revenue

Normalised EPS

546 Normalised EPS Unlock 546 Revenue

PE Ratio Range

546 PE Ratio Range Unlock 546 Revenue

Dividend Yield Range

546 Dividend Yield Range Unlock 546 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
546 EPS Forecasts Unlock 546 Revenue
Profile Summary

Medtecs International Corporation Limited is an integrated healthcare products and services provider in the Asia Pacific region. The Company is an original product manufacturing (OPM) manufacturer and distributor of healthcare, hospitality and work wear products for the global healthcare and hospitality industry. Its business segments are Manufacturing, Hospital Services, Distribution and Others. The Company offers various products, such as healthcare textiles work wear, medical devices and equipment, and hospitality textiles. It manufactures products, such as medical bandages, patient apparels, surgical drapes, crochet blankets and bed linens, and other medical supplies. It also acts as an agent for other branded medical supplies, devices and equipment in the Asia Pacific region. It has operations across the United States, Asia Pacific and Europe. Its facilities are located in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and the People's Republic of China.

Directors
Last Annual December 31st, 2018
Last Interim December 31st, 2018
Incorporated November 26, 1997
Public Since October 6, 1999
No. of Shareholders: n/a
No. of Employees: 1,589
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Singapore Exchange Securities Trading Ltd
Shares in Issue 549,411,240
Free Float (0.0%)
Eligible for
ISAs
SIPPs
546 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 546
Upcoming Events for 546
Frequently Asked Questions for Medtecs International
What is the Medtecs International share price?

As of 25/09/20, shares in Medtecs International are trading at S$1.22, giving the company a market capitalisation of £382.3m. This share price information is delayed by 15 minutes.

How has the Medtecs International share price performed this year?

Shares in Medtecs International are currently trading at S$1.22 and the price has moved by 3.71k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Medtecs International price has moved by 3.82k% over the past year.

What are the analyst and broker recommendations for Medtecs International?

There are no analysts currently covering Medtecs International.

When will Medtecs International next release its financial results?

Medtecs International is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2019-12-31
What is the Medtecs International dividend yield?

Medtecs International does not currently pay a dividend.

Does Medtecs International pay a dividend?

Medtecs International does not currently pay a dividend.

When does Medtecs International next pay dividends?

Medtecs International does not currently pay a dividend.

How do I buy Medtecs International shares?

To buy shares in Medtecs International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Medtecs International?

Shares in Medtecs International are currently trading at S$1.22, giving the company a market capitalisation of £382.3m.

Where are Medtecs International shares listed? Where are Medtecs International shares listed?

Here are the trading details for Medtecs International:

Country of listing: Singapore
Exchange: SES
Ticker Symbol: 546
What kind of share is Medtecs International?

We were not able to load our ranking data for Medtecs International

Is there a Medtecs International share price forecast 2020?

We were not able to load any forecast data for Medtecs International.

How can I tell whether the Medtecs International share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medtecs International. Over the past six months, the relative strength of its shares against the market has been 1.22k%. At the current price of S$1.22, shares in Medtecs International are trading at 0.185k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Medtecs International PE Ratio?

The Medtecs International PE ratio based on its reported earnings over the past 12 months is 0.508k. The shares are currently trading at S$1.22.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Medtecs International?

Medtecs International's management team is headed by:

Ker-Cheng Yang - CHM
Weiyuan Yang - CEO
Wilfrido Rodriguez - CFO
Junwei Xia - EDR
Abdul Jabbar Bin Karam Din - SEC
Tai Toon Lim - LED
Chien-Chung Nieh - IND
Cheok Phuan Tay - IND
Xiao-Qing Yang - IND
Who are the major shareholders of Medtecs International?

Here are the top five shareholders of Medtecs International based on the size of their shareholding:

Yang (Ker-Cheng) Individual Investor
Percentage owned: 10.51% (57.7m shares)
Holdrich International Ltd. Corporation
Percentage owned: 1.15% (6.32m shares)
Top Honesty International Corp. Corporation
Percentage owned: 1.15% (6.32m shares)
Morph Investments Ltd. Corporation
Percentage owned: 1.13% (6.20m shares)
Neo (Yam Cheng) Individual Investor
Percentage owned: 0.74% (4.09m shares)
Similar to 546
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.